Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas |
University of Manitoba / Tamra Werbowetski-Ogilvie, PhD |
Innovation Grants |
2017 |
Manitoba |
Targeting Pediatric Brain Tumors Using PTPmu Nanochains with Radiofrequency-Releasable Therapeutics |
Case Western Reserve University / Susann Brady-Kalnay, PhD & Efstathios Karathanasis, PhD |
Innovation Grants |
2017 |
Ohio |
Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-Free DNA |
University of Chicago / Susan Cohn, MD & Chuan He PhD |
Innovation Grants |
2017 |
Illinois |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children's Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Targeting Metabolic Vulnerabilities in ETP-ALL |
Columbia University / Adolfo A. Ferrando, MD/PhD |
Innovation Grants |
2017 |
New York |
Development of Mithramycin Analogs for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD/PhD |
Innovation Grants |
2017 |
Michigan |
Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS |
National Jewish Health / Jordan Jacobelli, PhD |
Innovation Grants |
2017 |
Colorado |
Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies |
University of California, Davis Medical Center / Paul Knoepfler, PhD |
Innovation Grants |
2017 |
California |
Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML |
Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD |
Innovation Grants |
2017 |
Washington |